On Friday, Cardiff Oncology Inc (NASDAQ: CRDF) opened lower -4.72% from the last session, before settling in for the closing price of $2.33. Price fluctuations for CRDF have ranged from $0.94 to $6.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 9.26% over the last five years. Company’s average yearly earnings per share was noted -5.11% at the time writing. With a float of $41.11 million, this company’s outstanding shares have now reached $44.68 million.
The firm has a total of 32 workers. Let’s measure their productivity.
Cardiff Oncology Inc (CRDF) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cardiff Oncology Inc is 8.09%, while institutional ownership is 18.95%. The most recent insider transaction that took place on Dec 19 ’23, was worth 41,100. In this transaction Director of this company bought 30,000 shares at a rate of $1.37, taking the stock ownership to the 697,761 shares.
Cardiff Oncology Inc (CRDF) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -5.11% per share during the next fiscal year.
Cardiff Oncology Inc (NASDAQ: CRDF) Trading Performance Indicators
Check out the current performance indicators for Cardiff Oncology Inc (CRDF). In the past quarter, the stock posted a quick ratio of 5.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 162.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.90, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Cardiff Oncology Inc (CRDF)
Analysing the last 5-days average volume posted by the [Cardiff Oncology Inc, CRDF], we can find that recorded value of 1.63 million was better than the volume posted last year of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 17.79%. Additionally, its Average True Range was 0.21.
During the past 100 days, Cardiff Oncology Inc’s (CRDF) raw stochastic average was set at 15.15%, which indicates a significant increase from 5.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.36% in the past 14 days, which was lower than the 126.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.33, while its 200-day Moving Average is $2.48. Now, the first resistance to watch is $2.30. This is followed by the second major resistance level at $2.37. The third major resistance level sits at $2.42. If the price goes on to break the first support level at $2.18, it is likely to go to the next support level at $2.13. Now, if the price goes above the second support level, the third support stands at $2.06.
Cardiff Oncology Inc (NASDAQ: CRDF) Key Stats
There are currently 44,725K shares outstanding in the company with a market cap of 99.28 million. Presently, the company’s annual sales total 490 K according to its annual income of -41,440 K. Last quarter, the company’s sales amounted to 210 K and its income totaled -10,010 K.
